FAEFHI

Last updated

FAEFHI
FAEFHI.svg
Clinical data
Other names4-(2-Aminoethyl)-5-hydroxyindole
Drug class Serotonin receptor modulator; Partial ergoline
ATC code
  • None
Identifiers
  • 4-(2-aminoethyl)-1H-indol-5-ol
PubChem CID
ChemSpider
Chemical and physical data
Formula C10H12N2O
Molar mass 176.219 g·mol−1
3D model (JSmol)
  • C1=CC(=C(C2=C1NC=C2)CCN)O
  • InChI=1S/C10H12N2O/c11-5-3-8-7-4-6-12-9(7)1-2-10(8)13/h1-2,4,6,12-13H,3,5,11H2
  • Key:CSFAMKTUFIKJAE-UHFFFAOYSA-N

FAEFHI, also known as 4-(2-aminoethyl)-5-hydroxyindole, is a serotonin receptor modulator of the indole group related to serotonin and other tryptamines. [1] [2] It is a positional isomer of serotonin in which the ethyl amine side chain at the 3 position of the indole ring system has been moved to the 4 position. [1] [2] FAEFHI can also be thought of as a greatly simplified analogue of LSD and hence partial ergoline. [1] [2] Although FAEFHI shows significant affinity for serotonin receptors, it had much lower affinity than serotonin or tryptamine (171-fold lower than serotonin and 5-fold lower than tryptamine). [1] [2] In addition, it did not show serotonin-like activity (i.e., serotonin receptor agonism) even at very high concentrations in vitro . [2] FAEFHI was first described in the scientific literature by 1984. [1] [2]

See also

References

  1. 1 2 3 4 5 Osman R, Mazurek AP, Weinstein H (18 January 1987). "Simulation of Molecular Stereoelectronic Mechanism for the Interaction of Hallucinogens and Indole Derivatives at 5-HT Receptors". Steric Aspects of Biomolecular Interactions. CRC Press. pp. 199–210. doi:10.1201/9781351076890-10. ISBN   978-1-351-07689-0 . Retrieved 1 June 2025.
  2. 1 2 3 4 5 6 Weinstein H, Osman R, Topiol S, Ebersole BJ, Mazurek AP (12 March 1984). "Theoretical and experimental studies of drug-receptor interactions: Determinants for recognition of 5-hydroxytryptamine analogs". International Journal of Quantum Chemistry. 26 (S11): 183–194. doi:10.1002/qua.560260719. ISSN   0020-7608 . Retrieved 1 June 2025. Two new compounds, 5-hydroxyaminotetrahydrobenzindole (FHATHBIN, 2 in Fig. l), and 4-(betu-aminoethyl)-5-hydroxyindole (FAEFHI, 3 in Fig. 1) provide additional opportunity to probe the hypotheses regarding recognition at high affinity 5-HT sites. FHATHBIN incorporates structural elements of the LSD molecule, but has an hydroxyl substituent in the 5-position instead of the C9-C10 double bond, while FAEFHI is an analog of 5-HT in which the aminoethyl side chain was moved from the 3-position of the indole, to the 4-position (see Fig. 1). Preliminary pharmacological data indicated that FHATHBIN had 5-HT-like activity at some receptors in the peripheral nervous system, while FAEFHI did not elicit 5-HT-like activity at concentrations far exceeding those at which 5-HT acted in the same systems [7]. [...] Figure 1. The molecular structures of 5-hydroxytryptamine (l), 5-hydroxyaminotetrahydrobenzindole (2), and 4-(bera-aminoethyl)-5-hydroxyindole (3). [...]



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.